Version 1
: Received: 22 July 2020 / Approved: 23 July 2020 / Online: 23 July 2020 (08:24:54 CEST)
How to cite:
Pedro, A. The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Preprints2020, 2020070541. https://doi.org/10.20944/preprints202007.0541.v1
Pedro, A. The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Preprints 2020, 2020070541. https://doi.org/10.20944/preprints202007.0541.v1
Pedro, A. The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Preprints2020, 2020070541. https://doi.org/10.20944/preprints202007.0541.v1
APA Style
Pedro, A. (2020). The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Preprints. https://doi.org/10.20944/preprints202007.0541.v1
Chicago/Turabian Style
Pedro, A. 2020 "The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales" Preprints. https://doi.org/10.20944/preprints202007.0541.v1
Abstract
Multicompartment compliance aids (MCAs) are devices with each discrete section denoting a single dosing occasion. The purpose of an MCA is to maximize patient adherence and thereby optimize the treatment benefits. These devices are widely employed throughout western Europe and UK and use appears to be rapidly increasing (2) although the RPS as moved away from these devices as a means to improve adherence. We analysed MCAs from various pharmacies over a wide geographic area in England and North Wales. We concluded that most MCA users are elderly patients. Also, most of the patients suffer of combined cardiovascular disease. However, a significant proportion of patients falls in the mental/ neurological disease category. Additionally, most of the externals added to MCAs are inhalers and painkillers. Moreover, SDIs are more frequent in female patients and these SDI are mainly related with mental health medication, cardiovascular disease medication and neurological medication. In conclusion, a directive for dispensing of MCAs in pharmacies by pharmacists through an enhanced service should be elaborated having in consideration PIMs, SDIs, drug stability and use of externals and MCA design and brand.
Keywords
MCAs; clinical pharmacy
Subject
Medicine and Pharmacology, Pharmacology and Toxicology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
